# Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock

> **NCT01150409** · PHASE4 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 11 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** hydrocortisone
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT01150409
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Difficulty in recruiting eligible subjects
- **Last updated:** 2018-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150409, "Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01150409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*